Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Julio Vallejos
Rodrigo Zoni
María Bangher
Silvina Villamandos
Angelina Bobadilla
Fabian Plano
Claudia Campias
Evangelina Chaparro Campias
Maria Fernanda Medina
Fernando Achinelli
Hector Andres Guglielmone
Jorge Ojeda
Diego Farizano Salazar
Gerardo Andino
Pablo Kawerin
Silvana Dellamea
Antonia Cristina Aquino
Victor Flores
Carolina N. Martemucci
Silvina Maria Martinez
Juan Emanuel Segovia
Paola Itati Reynoso
Noelia Carolina Sosa
Mariana Elizabeth Robledo
Joaquina Maria Guarrochena
Maria Mercedes Vernengo
Natalia Ruiz Diaz
Elba Meza
María Gabriela Aguirre
机构：
[1] Instituto de Cardiología de Corrientes,Hospital de Campaña
[2] Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes,undefined
[3] Ministerio de Salud Pública de la Provincia de Corrientes,undefined
[4] Ministerio de Salud Pública de Corrientes,undefined
[5] Ministerio de Salud Pública de la Provincia de Corrientes,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
    Vallejos, Julio
    Zoni, Rodrigo
    Bangher, Maria
    Villamandos, Silvina
    Bobadilla, Angelina
    Plano, Fabian
    Campias, Claudia
    Chaparro Campias, Evangelina
    Fernanda Medina, Maria
    Achinelli, Fernando
    Andres Guglielmone, Hector
    Ojeda, Jorge
    Farizano Salazar, Diego
    Andino, Gerardo
    Kawerin, Pablo
    Dellamea, Silvana
    Cristina Aquino, Antonia
    Flores, Victor
    Martemucci, Carolina N.
    Maria Martinez, Silvina
    Emanuel Segovia, Juan
    Itati Reynoso, Paola
    Carolina Sosa, Noelia
    Elizabeth Robledo, Mariana
    Maria Guarrochena, Joaquina
    Mercedes Vernengo, Maria
    Ruiz Diaz, Natalia
    Meza, Elba
    Gabriela Aguirre, Maria
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [2] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial
    Julio Vallejos
    Rodrigo Zoni
    Maria Bangher
    Silvina Villamandos
    Angelina Bobadilla
    Fabian Plano
    Claudia Campias
    Evangelina Chaparro Campias
    Fernando Achinelli
    Hector A. Guglielmone
    Jorge Ojeda
    Fernanda Medina
    Diego Farizano Salazar
    Gerardo Andino
    Natalia E. Ruiz Diaz
    Pablo Kawerin
    Elba Meza
    Silvana Dellamea
    Antonia Aquino
    Victor Flores
    Carolina N. Martemucci
    María Mercedes Vernengo
    Silvina María Martinez
    Juan Emanuel Segovia
    María Gabriela Aguirre
    [J]. Trials, 21
  • [3] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial
    Vallejos, Julio
    Zoni, Rodrigo
    Bangher, Maria
    Villamandos, Silvina
    Bobadilla, Angelina
    Plano, Fabian
    Campias, Claudia
    Chaparro Campias, Evangelina
    Achinelli, Fernando
    Guglielmone, Hector A.
    Ojeda, Jorge
    Medina, Fernanda
    Farizano Salazar, Diego
    Andino, Gerardo
    Ruiz Diaz, Natalia E.
    Kawerin, Pablo
    Meza, Elba
    Dellamea, Silvana
    Aquino, Antonia
    Flores, Victor
    Martemucci, Carolina N.
    Vernengo, Maria Mercedes
    Martinez, Silvina Maria
    Segovia, Juan Emanuel
    Aguirre, Maria Gabriela
    [J]. TRIALS, 2020, 21 (01)
  • [4] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Anan Manomaipiboon
    Kittisak Pholtawornkulchai
    Sujaree Poopipatpab
    Swangjit Suraamornkul
    Jakravoot Maneerit
    Wiroj Ruksakul
    Uraporn Phumisantiphong
    Thananda Trakarnvanich
    [J]. Trials, 23
  • [5] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Manomaipiboon, Anan
    Pholtawornkulchai, Kittisak
    Poopipatpab, Sujaree
    Suraamornkul, Swangjit
    Maneerit, Jakravoot
    Ruksakul, Wiroj
    Phumisantiphong, Uraporn
    Trakarnvanich, Thananda
    [J]. TRIALS, 2022, 23 (01)
  • [6] Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
    Shahbaznejad, Leila
    Davoudi, Alireza
    Eslami, Gohar
    Markowitz, John S.
    Navaeifar, Mohammad Reza
    Hosseinzadeh, Fatemeh
    Movahedi, Faeze Sadat
    Rezai, Mohammad Sadegh
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (06) : 1007 - 1019
  • [7] The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial
    Kasiri, Hossein
    Ghazaiean, Mobin
    Rouhani, Nima
    Naderi-behdani, Fahimeh
    Ghazaeian, Monireh
    Ghodssi-Ghassemabadi, Robabeh
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (02) : 124 - 131
  • [8] Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
    Rocco, Patricia R. M.
    Silva, Pedro L.
    Cruz, Fernanda F.
    Tierno, Paulo F. G. M. M.
    Rabello, Eucir
    Junior, Jefiton Cordeiro
    Haag, Firmino
    de avila, Renata E.
    da Silva, Joana D. G.
    Mamede, Mariana M. S.
    Buchele, Konrad S.
    Barbosa, Luiz C. V.
    Cabral, Anna C.
    Junqueira, Antonio A. F.
    Araujo-Filho, Joao A.
    da Costa, Lucianna A. T. J.
    Alvarenga, Pedro P. M.
    Moura, Alexandre S.
    Carajeleascow, Ricardo
    de Oliveira, Mirella C.
    Silva, Roberta G. F.
    Soares, Cynthia R. P.
    Fernandes, Ana Paula S. M.
    Fonseca, Flavio Guimaraes
    Camargos, Vidyleison Neves
    Reis, Julia de Souza
    Franchini, Kleber G.
    Luiz, Ronir R.
    Morais, Sirlei
    Sverdloff, Carlos
    Martins, Camila Marinelli
    Felix, Nathane S.
    Mattos-Silva, Paula
    Nogueira, Caroline M. B.
    Caldeira, Dayene A. F.
    Pelosi, Paolo
    Lapa-e-Silva, Jose R.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [9] Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Huang, Daniel Q.
    Ajmera, Veeral
    Tomaszewski, Christian
    LaFree, Andrew
    Bettencourt, Ricki
    Thompson, Wesley K.
    Smith, Davey M.
    Malhotra, Atul
    Mehta, Ravindra L.
    Tolia, Vaishal
    Yin, Jeffrey
    Insel, Paul A.
    Leachman, Stone
    Jung, Jinho
    Collier, Summer
    Richards, Lisa
    Woods, Kristin
    Amangurbanova, Maral
    Bhatt, Archana
    Zhang, Xinlian
    Penciu, Oana M.
    Zarich, Stuart
    Retta, Tamrat
    Harkins, Michelle S.
    Teixeira, J. Pedro
    Chinnock, Brian
    Utay, Netanya S.
    Lake, Jordan E.
    Loomba, Rohit
    [J]. ADVANCES IN THERAPY, 2023, 40 (11) : 4805 - 4816
  • [10] Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Yan-rong
    Wu, Feng-yao
    Xiao, Huan
    Huang, Jian-lin
    Gong, Bei-bei
    Li, You-ling
    Lu, Ning
    Jiang, Xiao-hong
    Sun, Qi-xiang
    Zhang, Jian-feng
    Hu, Jun-tao
    Zhao, Yong-xiang
    Li, Chao-qian
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (02) : 108 - 114
12345